Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E Gene Polymorphisms In Patients With Migraine

I. Rainero, L. Grimaldi, G. Salani, W. Valfrè, L. Pinessi
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
To investigate the role of apolipoprotein E (APOE) polymorphisms in migraine, we analyzed the APOE genotypes of 241 migraine patients and 587 controls. The results of a Chi-square analysis indicated that APOE alleles were similarly distributed (chi(2)=2.89, P=0.24) between cases and controls. However, we found a significant (P<0.001) increase of the varepsilon2-varepsilon4 genotype in the group of migraine patients. Patients were divided into three subgroups: migraine with aura; migraine without aura; and mixed headaches (migraine associated with tension-type headache). Subgroup analysis showed that the varepsilon2-varepsilon4 genotype was significantly increased only in patients with mixed headaches. The stratification of patients by APOE status did not reveal significant associations with the clinical features of the disease. In conclusion, we observed no significant association between APOE polymorphisms and migraine. The association between the APOE varepsilon2-varepsilon4 genotype and the tension-type headache deserves further evaluation.
This paper references
10.1111/j.1468-2982.1998.1805257.x
Migraine and Prothrombotic Genetic Risk Factors
J. Corral (1998)
10.1046/j.1468-2982.2001.00181.x
Evidence for Activation of the Coagulation System in Migraine with Aura
R. Hering-Hanit (2001)
10.1093/JNEN/59.9.751
Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses
A. Saunders (2000)
10.1038/NG0198-69
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
M. Bullido (1998)
10.1002/ANA.410340527
The apolipoprotein ε4 allele in patients with Alzheimer's disease
R. Mayeux (1993)
10.1046/j.1468-2982.1988.0801001.x
Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study
Fulvio Sorge (1988)
10.1016/S0140-6736(97)04318-3
Association of apolipoprotein E polymorphism with outcome after head injury
G. Teasdale (1997)
10.1159/000026233
The Relationship of Migraine and Stroke
G. Tietjen (1999)
10.1016/0140-6736(91)92823-K
Apolipoprotein E genotyping by one-stage PCR
P. Wenham (1991)
10.1001/ARCHNEUR.57.11.1561
Apolipoprotein E and neuromuscular disease: a critical review of the literature.
R. Bedlack (2000)
10.1111/j.1526-4610.1975.hed1501018.x
“COMPLICATED MIGRAINE” ITS ASSOCIATION WITH INCREASED PLATELET AGGREGABILITY AND ABNORMAL PLASMA COAGULATION FACTORS
Z. Kalendovsky (1975)
10.7326/0003-4819-73-6-1055_1
Mechanism and management of headache
J. Lance (1973)
10.1046/j.1468-2982.1991.1101019.x
Anticardiolipin Antibodies in Migraine
R. Hering (1991)
10.1136/jnnp.67.2.203
Association of the APOE ε4 allele with disease activity in multiple sclerosis
N. Evangelou (1999)
10.1056/NEJM200001273420403
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.
H. O'donnell (2000)
10.1212/WNL.53.6.1308
APOE genotype as a risk factor for ischemic cerebrovascular disease
M. McCarron (1999)
10.1016/S0165-5728(00)00459-8
Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response
J. Lynch (2001)
10.1001/ARCHNEUR.1997.00550160012009
Association between migraine and stroke in a large-scale epidemiological study of the United States.
K. Merikangas (1997)



This paper is referenced by
10.1089/ars.2017.7260
Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions.
P. Ferroni (2018)
9. Migraine and coronary artery disease: An updated open study on the genetic polymorphism
A. Capasso (2013)
10.1097/WNR.0b013e3283625f55
Investigation of APOE isoforms and the association between APOE E3 and E4 with migraine in the Australian Caucasian population
S. Stuart (2013)
10.1007/s10620-008-0271-5
Association of Apolipoprotein E Polymorphisms in Patients with Non-Alcoholic Steatohepatitis
Ali Sazci (2008)
Avaluació de gens de susceptibilitat a formes comunes de migranya
R. Castiñeira (2009)
10.2174/1874205X01206010065
Migraine and Genetic Polymorphisms: An Overview
V. Pizza (2012)
10.1089/dna.2010.1197
Vascular gene polymorphisms (EDNRA -231 G>A and APOE HhaI) and risk for migraine.
G. Joshi (2011)
10.1186/s12883-015-0385-2
Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis
J. Miao (2015)
10.1371/journal.pone.0190620
Serum apolipoprotein E may be a novel biomarker of migraine
Naoki Yuasa (2018)
10.1016/j.jns.2016.08.008
Biomarkers of migraine: Part 1 – Genetic markers
N. Kondratieva (2016)
10.1016/j.mehy.2018.02.033
Role of Apolipoprotein E in the tangled mystery of pain.
Harjot Dhillon (2018)
10.1080/13803395.2016.1177491
Relationship between the apolipoprotein E gene and headache following sports-related concussion
V. Merritt (2016)
10.1007/s10194-008-0094-y
Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects
R. Gupta (2008)
10.1038/jcbfm.2008.36
Migraine and Ischemic Stroke: A Debated Question
E. Del Zotto (2008)
10.1007/s00439-003-1055-9
Update on the genetics of migraine
M. Estévez (2003)
10.1586/14737175.4.3.415
Etiology of primary headaches: the importance of genes and environment
D. Svensson (2004)
Semantic Scholar Logo Some data provided by SemanticScholar